Literature DB >> 34286221

Family Medicine Residents' Experience During Early Phases of the COVID-19 Pandemic.

Dean A Seehusen1, Amanda Kost2, Wendy B Barr3, Mary Theobald4, Diane M Harper5, Aimee R Eden6.   

Abstract

BACKGROUND AND OBJECTIVES: Residents have been thrust onto the front lines of the US medical response to COVID-19. This study aimed to quantify and describe the experiences of family medicine residents nationally during the early phases of the pandemic. Specific areas of interest included training received and the residents' personal sense of safety. The purpose of this study was to look for differences among residents based on geographic location.
METHOD: This May 2020 survey was conducted by the Council of Academic Family Medicine Educational Research Alliance (CERA) of a random sample of 5,000 resident members of the American Academy of Family Physicians (AAFP).
RESULTS: The overall response rate for the survey was 5.66% (283/5,000). More than 40% of residents reported having felt in moderate to significant personal danger during the COVID-19 pandemic. Fewer than 20% had been tested for COVID-19 themselves. Among all respondents, 176 (65.7%) of the residents had provided direct patient care for COVID-19-positive patients. Most had been trained on personal protective equipment and the medical aspects of COVID-19, but 16.2% reported no training on how to care for COVID-19 patients. Minority residents, and residents in larger urban areas were less likely to receive timely training.
CONCLUSIONS: The COVID-19 pandemic has had a major impact on family medicine residents' medical education and their sense of safety. Regional variations in residents' educational experiences during the pandemic exist. Training prior to COVID-19 exposure was not universal. In our sample, minority residents were less likely to receive timely training than White residents.
© 2021 by the Society of Teachers of Family Medicine.

Entities:  

Year:  2021        PMID: 34286221      PMCID: PMC8284493          DOI: 10.22454/PRiMER.2021.909862

Source DB:  PubMed          Journal:  PRiMER        ISSN: 2575-7873


  8 in total

1.  ACGME's Early Adaptation to the COVID-19 Pandemic: Principles and Lessons Learned.

Authors:  Thomas J Nasca
Journal:  J Grad Med Educ       Date:  2020-06

2.  COVID-19 and Family Doctors.

Authors:  Frederick M Chen
Journal:  Fam Med       Date:  2020-04       Impact factor: 1.756

3.  Creating a Centralized Infrastructure to Facilitate Medical Education Research.

Authors:  Dean A Seehusen; Arch G Mainous; Alexander W Chessman
Journal:  Ann Fam Med       Date:  2018-05       Impact factor: 5.166

Review 4.  Racism In My Medical Education.

Authors:  Michelle Ko
Journal:  Health Aff (Millwood)       Date:  2020-06       Impact factor: 6.301

5.  Medical and Surgical Education Challenges and Innovations in the COVID-19 Era: A Systematic Review.

Authors:  Panagiotis Dedeilias; Michail Sideris; Aikaterini Dedeilia; Marinos G Sotiropoulos; John Gerrard Hanrahan; Deepa Janga
Journal:  In Vivo       Date:  2020-06       Impact factor: 2.155

6.  The Impact of COVID-19 on Medical Education.

Authors:  Meganne N Ferrel; John J Ryan
Journal:  Cureus       Date:  2020-03-31

7.  Notes From the Eye of the Storm: Trainees at the Frontlines of the COVID-19 Pandemic.

Authors:  Joshua Berookhim; Ashish Correa; Jacqueline E Tamis-Holland
Journal:  J Am Coll Cardiol       Date:  2020-05-15       Impact factor: 24.094

8.  Five Questions for Residency Leadership in the Time of COVID-19: Reflections of Chief Medical Residents From an Internal Medicine Program.

Authors:  Shana Rakowsky; Bess M Flashner; Jim Doolin; Zachary Reese; Jason Shpilsky; Shu Yang; C Christopher Smith; Kelly Graham
Journal:  Acad Med       Date:  2020-08       Impact factor: 6.893

  8 in total
  1 in total

1.  Australian general practice registrars' experiences of training, well-being and support during the COVID-19 pandemic: a qualitative study.

Authors:  Isabella White; Jill Benson; Taryn Elliott; Lucie Walters
Journal:  BMJ Open       Date:  2022-06-20       Impact factor: 3.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.